UMIN ID: UMIN000001900
Registered date:23/04/2009
PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Chronic Myeloid Leukemia (chronic phase) |
| Date of first enrollment | 2009/04/01 |
| Target sample size | 60 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Dasatinib |
Outcome(s)
| Primary Outcome | MMR rate |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 15years-old |
|---|---|
| Age maximum | 99years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | double cancer pregnancy etc |
Related Information
| Primary Sponsor | Inter-Michinoku Dasatinib Study(IMIDAS) |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Inter-Michinoku Dasatinib Study(IMIDAS) |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Uchimaru19-1,Morioka,Japan Japan |
| Telephone | |
| Affiliation | Iwate Medical University hematology/oncology |
| scientific contact | |
| Name | Yoji Ishida |
| Address | Uchimaru19-1,Moriaka,Japan Japan |
| Telephone | |
| Affiliation | Iwate Medical Unversity, Internal Medicine hematology/oncology |